Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 39172760

Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2024 Dec 5
First author
Touzeau C

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Touzeau C
      type
      Author
    2. name
      Krishnan AY
      type
      Author
    3. name
      Moreau P
      type
      Author
    4. name
      Perrot A
      type
      Author
    5. name
      Usmani SZ
      type
      Author
    6. name
      Manier S
      type
      Author
    7. name
      Cavo M
      type
      Author
    8. name
      Martinez Chamorro C
      type
      Author
    9. name
      Nooka AK
      type
      Author
    10. name
      Martin TG
      type
      Author
    11. name
      Karlin L
      type
      Author
    12. name
      Leleu X
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Touzeau C
      type
      Author
    2. name
      Krishnan AY
      type
      Author
    3. name
      Moreau P
      type
      Author
    4. name
      Perrot A
      type
      Author
    5. name
      Usmani SZ
      type
      Author
    6. name
      Manier S
      type
      Author
    7. name
      Cavo M
      type
      Author
    8. name
      Martinez Chamorro C
      type
      Author
    9. name
      Nooka AK
      type
      Author
    10. name
      Martin TG
      type
      Author
    11. name
      Karlin L
      type
      Author
    12. name
      Leleu X
      type
      Author
    bibliography ids
    1. nci-bib-154021625fc923c76c8463f2
    book metadata
    content sha256
    ed6a2aad8f2fddac8ad2e07ce9b72d3f176704a385ba4009cc4cfe1e6ad8993a
    document type
    citation
    dois
    1. 10.1182/blood.2023023616
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:39172760
    immutable id
    pubmed:39172760@ed6a2aad8f2fddac8ad2e07ce9b72d3f176704a385ba4009cc4cfe1e6ad8993a
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    23
    name
    Blood
    nlm unique id
    7603509
    pages
    2375-2388
    volume
    144
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      39172760
      provenance
      batch id
      3e43afde6f26fc8df6da
      provider
      NCBI PubMed ESummary
      record sha256
      826caaf77d1701fa7382c4453a0a5a2bcc27aaed54028121e3998cc8f32e80df
      response sha256
      fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
      retrieved at
      2026-09-09T23:48:21.145285+00:00
      publication date
      display
      2024 Dec 5
      precision
      day
      year
      2024
      publication types
      1. Journal Article
      2. Clinical Trial, Phase II
      3. Clinical Trial, Phase I
      4. Multicenter Study
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/39172760/
      title
      Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies.

      Preserved source evidence · Not medical advice